|
Details Of Insider Trading Activities
Transaction | Company | Ticker | Insider | Shares Traded | Avg. Price | Total Value | Filing |
---|
2018-11-21 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 80,000 | $19.25 | $1,540,000 |  | 2018-01-16 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 66,000 | $28.03 | $1,849,980 |  | 2018-01-05 Purchase | CRISPR Therapeutics AG | CRSP | BAYER AKTIENGESELLSCHAFT 10% owner | 527,472 | $22.75 | $11,999,988 |  | 2018-01-05 Sale | CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director | 92,337 | $26.96 | $2,489,405 |  | 2018-01-05 Purchase | CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director | 65,934 | $22.75 | $1,499,998 |  | 2018-01-02 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 38,000 | $21.64 | $822,320 |  | 2018-01-02 Sale | CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director | 37,754 | $26.76 | $1,010,297 |  | 2017-12-29 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 30,300 | $22.74 | $689,022 |  | 2017-12-28 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 700 | $21.75 | $15,225 |  | 2017-12-22 Sale | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 3,059 | $20.29 | $62,067 |  | 2017-12-22 Sale | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 26,016 | $20.30 | $528,124 |  | 2017-12-22 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 15,000 | $20.55 | $308,250 |  | 2017-12-15 Sale | CRISPR Therapeutics AG | CRSP | Dylan-Hyde Tyler Chief Legal Officer | 15,000 | $18.90 | $283,500 |  | 2017-12-04 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 30,485 | $19.47 | $593,542 |  | 2017-12-01 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 87,991 | $19.10 | $1,680,628 |  | 2017-11-30 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 12,666 | $19.04 | $241,160 |  | 2017-11-29 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 4,263 | $19.25 | $82,062 |  | 2017-11-28 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 5,080 | $19.22 | $97,637 |  | 2017-11-27 Sale | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 200 | $20.24 | $4,047 |  | 2017-11-27 Sale | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 200 | $20.24 | $4,047 |  | 2017-11-27 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 27,990 | $19.75 | $552,802 |  | 2017-11-24 Sale | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,507 | $20.21 | $30,456 |  | 2017-11-24 Sale | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,700 | $20.21 | $34,357 |  | 2017-11-24 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 26,010 | $20.00 | $520,200 |  | 2017-11-22 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 256,000 | $19.76 | $5,058,560 |  | 2017-11-20 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 158,718 | $19.02 | $3,018,816 |  | 2017-11-17 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 51,282 | $18.44 | $945,640 |  | 2017-11-16 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 105,000 | $18.39 | $1,930,950 |  | 2017-11-15 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 15,000 | $17.67 | $265,050 |  | 2017-11-14 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 14,907 | $17.19 | $256,251 |  | 2017-11-13 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 65,093 | $17.76 | $1,156,051 |  | 2017-11-10 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 10,000 | $17.28 | $172,800 |  | 2017-11-09 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 20,000 | $17.08 | $341,599 |  | 2017-11-08 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 16,875 | $18.06 | $304,762 |  | 2017-11-07 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 23,000 | $18.54 | $426,420 |  | 2017-11-06 Sale | CRISPR Therapeutics AG | CRSP | CELGENE CORP /DE/ 10% owner | 79,327 | $18.89 | $1,498,487 |  |
1
2
3
4
Next >
|
|
|